May 5, 2020 / 7:59 PM / 2 months ago

BRIEF-FDA Approves Dr. Reddy's Laboratories' Elyxyb Oral Solution For Acute Treatment Of Migraine With Or Without Aura In Adults

May 5 (Reuters) - FDA:

* FDA GRANTS APPROVAL FOR ELYXYB ORAL SOLUTION INDICATED FOR ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS TO DR. REDDY’S LABORATORIES

* FDA APPROVES DR. REDDY’S LABORATORIES' ELYXYB ORAL SOLUTION WITH A BOXED WARNING FOR RISK OF SERIOUS CARDIOVASCULAR & GASTROINTESTINAL EVENTS - LABEL Source text: (bit.ly/3cacrmL) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below